For research labsIndia-groundedCo-authorship · No IP grab

Collaborate with PetriDish

PetriDish is built for Indian biomedicine — 4.4M knowledge-graph edges, 55 PGx variants, 100 phytochemicals, 50 curated epifactors, all India-frequency-weighted. We're actively looking for senior PIs, hospital cohorts, and AYUSH-integration labs to co-author the validation work. Three open collaboration tracks below; pick the one that fits your lab and ping us.

Track 1 · Clinical validation8–12 weeks to preprint

Co-author a validation paper

PetriDish has 9 working modules, no clinical validation paper yet. We'd like to fix that with your patient cohort + your senior author position.

  • Knowledge graph + 55 PGx variants + IndiGen frequencies
  • Live API endpoints (sub-200ms PGx safety check)
  • Engineering time to build the cohort-specific dashboard
  • Statistical analysis + preprint drafting support
  • Co-author credit · no IP claim on your cohort data
  • Retrospective or prospective cohort (>100 patients ideal)
  • Pharmacy / lab data linked to outcomes
  • Ethics committee clearance for retrospective use
  • Senior-author position
Output: Joint preprint within 8–12 weeks; pursue a Lancet South-East Asia / Indian J Pharmacol submission.
Track 2 · Phytochemical curation4–6 weeks to first launch

Help us scale IMPPAT 100 → 500

PetriDish has 100 curated phytochemicals with SMILES + 192 MAMMAL DTI predictions. ACTREC, IIIT-D, and CDFD have larger Indian phytochemistry corpora. Cross-licence them in.

  • Existing IMPPAT 100 + MAMMAL DTI scoring infra
  • Pipeline to ingest CSV → Neo4j → API in <1 day
  • PubMed citation annotation per compound
  • Visible attribution: your lab as a data source on /methods
  • Public or shareable phytochemistry dataset
  • SMILES, herb-of-origin, optional bioactivity priors
  • Lab review of our drug-target predictions for your top 20 compounds
Output: Joint /ayurbridge product launch; PetriDish becomes the search layer over your data.
Track 3 · Multi-omics integration6–10 weeks to working demo

Bring scGPT / methylome / spatial

EpiOnco today is a curated knowledge layer over published Indian signatures. If your lab runs scRNA-seq, EPIC arrays, or spatial — there's a path to ingest cohort embeddings into the Tumour Ability Score.

  • Tumour Ability Score framework (India delta)
  • 14 cancer hallmarks + 50 epifactor knowledge layer
  • Engineering to wire your embeddings into TAS computation
  • Patient-facing TAS brief PDF generator
  • Sample-level embeddings or normalized expression / methylation
  • Cohort metadata (cancer type, stage, treatment, outcome)
  • Bioinformatician collaboration during integration
Output: Cohort-specific EpiOnco that the senior PI demos at AIIMS / Tata Memorial.

Five live use cases

Concrete starting points if you're not sure which track fits. Each maps to a real PetriDish module already running in production.

🧬
Pediatric leukemia PGx audit
Retrospective NUDT15 / TPMT genotype vs maintenance-phase ANC trajectory in 200 B-ALL kids. We do the PGx analysis, you publish.
Fit · Pediatric oncology · Hematology
💊
Stent thrombosis CYP2C19 cohort
Post-PCI patients on clopidogrel. Match CYP2C19*2/*3 status to MACE outcomes. India under-represented in trial-derived guidelines.
Fit · Interventional cardiology
🌿
Ayurvedic herb-CYP interaction registry
Build the first Indian registry of clinically documented herb-drug interactions. Start with the 12 we&apos;ve curated. Grow to 100 over 6 months.
Fit · Pharmacology · AYUSH integration
🔬
Indian OSCC methylome panel
Validate the hypomethylated p53 / DNMT3A signature in a fresh cohort. PetriDish provides the EpiOnco scoring layer.
Fit · Head-neck oncology · Epigenomics
🏥
Hospital PGx CDSS pilot
Embed /pgx/check into your EHR prescribing flow. Measure alert acceptance, prescription changes, and patient outcomes over 6 months.
Fit · Hospital informatics · CMIO

Get in touch

Email Shailesh with your lab, cohort size, and which track interests you. Reply within 48 hours. If there's a fit, we'll set up a 30-min Zoom + share a one-page MoU template.